Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2993 Target Snapshot

Amine oxidase [flavin-containing] B · SINGLE PROTEIN · Rattus norvegicus

1,659Compounds
344Assays
18Approved Drugs
1,645.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P19643. Use UniProt P19643 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P19643 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Amine oxidase [flavin-containing] B as ChEMBL target CHEMBL2993, mapped to UniProt P19643. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Amine oxidase [flavin-containing] B
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL2993
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P19643
Amine oxidase [flavin-containing] B
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Amine oxidase [flavin-containing] B is the right protein anchor across sources, using UniProt P19643 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAmine oxidase [flavin-containing] B
UniProt AccessionP19643
Component TypeProtein
Sequence Length520 aa

Amine oxidase [flavin-containing] B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Amine oxidase [flavin-containing] B, mapped to UniProt P19643. Sequence length is 520 aa.

Mapped IDP19643
Review nameAmine oxidase [flavin-containing] B
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

18
Approved
1
Phase III
10
Phase II
Assay Mix

Activity Type Distribution

IC501,451.0
KI194.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2022927 10.6 IC50 0.025 Preclinical
CHEMBL276076 9.4 IC50 0.4 Preclinical
CHEMBL1760721 9.35 Ki 0.45 Preclinical
CHEMBL8706 9.3 IC50 0.5 Clinical
CHEMBL274029 9.3 IC50 0.5 Preclinical
CHEMBL274030 9.22 IC50 0.6 Preclinical
CHEMBL1760722 9.22 Ki 0.6 Preclinical
CHEMBL45069 9.12 Ki 0.75 Preclinical
CHEMBL274513 9.1 IC50 0.8 Preclinical
CHEMBL19004 9.05 IC50 0.9 Clinical
Distribution

pChEMBL Value Distribution

154
5.0
167
5.5
155
6.0
113
6.5
113
7.0
102
7.5
111
8.0
46
8.5
14
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

SAFINAMIDE
CHEMBL396778
Approved 2015
RASAGILINE
CHEMBL887
Approved 2005
RASAGILINE MESYLATE
CHEMBL1201142
Approved 2005
SELEGILINE
CHEMBL972
Approved 1989
SELEGILINE HYDROCHLORIDE
CHEMBL1200904
Approved 1989
PARGYLINE
CHEMBL673
Approved 1982
PHENELZINE
CHEMBL1089
Approved 1961
Assay Landscape

Assay Landscape

344
Total Assays
1,224
Tested Compounds
2
Assay Types
Binding — 331 assays, 1,224 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 109 364 6.4
tissue-based format 91 315 6.0
single protein format 69 302 6.5
mitochondrion format 33 190 5.8
organism-based format 22 0
cell-based format 3 37 6.9
cell membrane format 2 14 6.4
cell-free format 1 1 8.5
subcellular format 1 1 7.3
Functional — 13 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 7 0
assay format 5 1 4.7
tissue-based format 1 1 4.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine